WS #16837

The market has decisively rotated following the Democratic sweep of Congress, shifting capital away from defense and energy incumbents toward healthcare, tech, and consumer discretionary. RTX and Lockheed Martin are down over 2% in premarket trading as the political balance of power changes, while CVS Health leads the healthcare sector with a massive earnings beat and a transformative corporate split announcement. This rotation is corroborated by Bitcoin rebounding from its midterm dip and futures moving green, indicating a broad risk-on sentiment that favors growth and domestic consumption over geopolitical hedges. In the technology sector, NVIDIA faces a specific supply constraint narrative as major Chinese firms (Alibaba, Tencent, ByteDance) receive only a fraction of their $70B order for RTX Pro 5500 chips due to production limitations, a headwind that counters the broader AI enthusiasm. Conversely, Microsoft and Nvidia are launching an AI support scheme in the UK and Ireland, highlighting a bifurcated global AI strategy. Meanwhile, Oracle has reportedly terminated a $7B chip-leasing deal with Tencent following US government pressure, signaling tightening enforcement of export controls. Earnings activity is dominated by CVS Health (beat and split), Cencora (beat), and Zimmer Biomet (beat), while Westlake Corporation missed EPS estimates. The macro environment is further complicated by Eurozone inflation jumping to 4% in October, driven by energy prices, which may influence ECB policy expectations. A potential summit between Trump, Xi, and Putin in Shenzhen is also being discussed, adding a layer of geopolitical uncertainty to the current political realignment.